EMA OKs First Drug To Prevent RSV Infection In Babies
Takeda Pulls EU Filing For Exkivity To Prevent CHMP Rejection
A new medicine to protect newborns and infants from RSV infection and a new treatment for DLBCL are among a dozen drugs that have been recommended for pan-EU approval.